Bio-Techne Corporation
TECH
Rank in Stocks
#1874
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Share Price
$72.55
Last synced: 2026-10-16
Market Cap
$11.38B
Change (1 day)
0.03%
Change (1 year)
17.27%
Country
US
Trade Bio-Techne Corporation (TECH)
Category
Healthcare
Revenue for Bio-Techne Corporation (TECH)
Revenue in Jun 2026 TTM: $1.22B
According to Bio-Techne Corporation latest financial reports the company's current revenue (TTM) is $1.22B. In 2024 the company made a revenue of $1.16B an increase over the revenue in the year 2023 that was $1.14B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bio-Techne Corporation from 2000 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $1.22B | -0.38% |
| 2025 | $1.22B | 5.23% |
| 2024 | $1.16B | 1.97% |
| 2023 | $1.14B | 2.81% |
| 2022 | $1.11B | 18.75% |
| 2021 | $931.03M | 26.04% |
| 2020 | $738.69M | 3.46% |
| 2019 | $714.01M | 11.04% |
| 2018 | $642.99M | 14.21% |
| 2017 | $563.00M | 12.82% |
| 2016 | $499.02M | 10.34% |
| 2015 | $452.25M | 26.41% |
| 2014 | $357.76M | 15.19% |
| 2013 | $310.58M | -1.27% |
| 2012 | $314.56M | 8.48% |
| 2011 | $289.96M | 7.77% |
| 2010 | $269.05M | 1.93% |
| 2009 | $263.96M | 2.54% |
| 2008 | $257.42M | 15.19% |
| 2007 | $223.48M | 10.30% |
| 2006 | $202.62M | 13.41% |
| 2005 | $178.65M | 10.79% |
| 2004 | $161.26M | 11.20% |
| 2003 | $145.01M | 10.78% |
| 2002 | $130.90M | 13.47% |
| 2001 | $115.36M | 11.09% |
| 2000 | $103.84M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $12.62B | 939.00% |
US
|
|
| $2.23B | 83.37% |
US
|
|
| $15.74B | 1,195.79% |
AU
|
|
| - | - |
CH
|
|
| $6.02B | 395.56% |
NL
|
